. Author manuscript; available in PMC: 2009 Dec 1.

Published in final edited form as: Int J Cancer. 2008 Dec 1;123(11):2566–2573. doi: 10.1002/ijc.23898

Table 3.

Heparanase staining extent correlates with LVD and VEGF C levels.

Heparanase extent	0-1	2	Total	p
Parameter	0-1	2	Total	p
Lymphatic vessels density				0.04
0-1	18 (35%)	33 (65%)	51
2	1 (7%)	13 (93%)	14
	19	46	65
Tumor cells in lymphatic vessels				0.02
No	18 (35%)	34 (65%)	52
Yes	0	11 (100%)	11
	18	45	63^*
VEGF C Intensity				0.01
0	6 (67%)	3 (33%)	9
1 (low)	7 (33%)	14 (67%)	21
2 (high)	2 (11%)	16 (89%)	18
	15	33	48

Heparanase localization	Nuclear	Cytoplasmic		0.04
VEGF C intensity	Nuclear	Cytoplasmic		0.04
0	7 (78%)	2 (22%)	9
1 (low)	17 (81%)	4 (19%)	21
2 (high)	8 (44%)	10 (56%)	18
	32	16	48

Data of two patients were missing